Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases.

Rademaker, Marius; Baker, Christopher; Foley, Peter; Sullivan, John; Wang, Charlie

Rademaker, Marius; Baker, Christopher; Foley, Peter; Sullivan, John; Wang, Charlie.

Rademaker M; Waikato Hospital - Waikato Clinical Campus, University of Auckland's Faculty of Medical and Health Sciences Hamilton, Hamilton, New Zealand.
Baker C; The University of Melbourne - Dermatology, Fitzroy, Victoria, Australia.
Foley P; Skin Health Institute, Carlton, Victoria, Australia.
Sullivan J; Skin Health Institute, Carlton, Victoria, Australia.
Wang C; The University of Melbourne, Melbourne, Victoria, Australia.

Australas J Dermatol ; 61(2): 158-159, 2020 May.

Article in English | MEDLINE | ID: covidwho-506185

Subject(s)

Coronavirus Infections/complications; Immunologic Factors/therapeutic use; Pneumonia, Viral/complications; Skin Diseases/drug therapy; Adrenal Cortex Hormones/administration & dosage; Adrenal Cortex Hormones/therapeutic use; Betacoronavirus; COVID-19; Comorbidity; Humans; Immunologic Factors/administration & dosage; Pandemics; SARS-CoV-2; Skin Diseases/complications

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Skin Diseases / Coronavirus Infections / Immunologic Factors Topics: Long Covid Limits: Humans Language: English Journal: Australas J Dermatol Year: 2020 Document Type: Article Affiliation country: Ajd.13295

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google